Results 221 to 230 of about 30,192 (236)

Replacing septal reduction therapy with mavacamten for HCM

Medicom Conference Report ACC 2022, 2022
Milind Desai, Rachel Giles
openaire   +1 more source

Septal reduction therapies for obstructive hypertrophic cardiomyopathy: Current strategies and evolving innovations

Trends in Cardiovascular Medicine
In symptomatic patients with obstructive hypertrophic cardiomyopathy, the management of left ventricular outflow tract obstruction remains the central therapeutic challenge. Despite recent advances in pharmacologic therapy, septal reduction therapy continues to represent the gold standard for relieving obstruction.
Hao Cui, Yongqiang Lai, Hartzell V. Schaff   +2 more
openaire   +2 more sources

Sex Differences in the Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

JACC: Cardiovascular Interventions, 2021
Jayakumar, Sreenivasan, Muhammad Shahzeb, Khan, Risheek, Kaul, Dhrubajyoti, Bandyopadhyay, Urvashi, Hooda, Wilbert S, Aronow, Howard A, Cooper, Julio A, Panza, Srihari S, Naidu   +8 more
openaire   +2 more sources

Pacing for heart block after septal reduction therapy

The American Journal of Cardiology, 2004
openaire   +1 more source

Efficacy of Cardiac Myosin Inhibition in Patients After Septal Reduction Therapy

The American Journal of Cardiology
Aakash Bavishi, Robyn Bryde, Marybeth Soutar, Margaret Kurnides, Heather Speer, Glenda Oyarce, Karen Richards, Karen DeMarco, Matthew W. Martinez   +8 more
openaire   +2 more sources

Procedural Volume and Outcomes of Septal Reduction Therapies in Patients With Hypertrophic Obstructive Cardiomyopathy

JAMA Cardiology, 2017
Sidakpal S, Panaich, Ankit, Chothani, Apurva O, Badheka   +2 more
openaire   +2 more sources

A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy

JACC: Heart Failure, 2015
, , Pieter Vriesendorp
exaly  

Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy

Journal of the American College of Cardiology, 2003
Sherif Nagueh, Su Min Chang, Nasser M Lakkis   +2 more
exaly  

Septal reduction therapy using nonalcohol agent in hypertrophic obstructive cardiomyopathy: Single center experience

Catheterization and Cardiovascular Interventions, 2018
Uğur Canpolat, Serkan Asil
exaly  

Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

Journal of the American College of Cardiology, 1999
Sherif Nagueh, Nasser M Lakkis, N M Lakkis   +2 more
exaly